EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Adherence in the Treatment of Inflammatory Bowel Disease With Particular Focus on the Importance of the Clinical Pharmacist: A Systematic Review

Faria Sayed iD, Mark Andrew Ainsworth iD

Basic & Clinical Pharmacology & Toxicology · 2025

DOI: 10.1111/bcpt.70125 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Faria Sayed und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Pharmacists, Medication Adherence, Pharmacy Service, Hospital. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The prevalence of inflammatory bowel disease (IBD) is increasing. While several studies have shown that incorporating a clinical pharmacist into patient care can improve quality of life, evidence specifically addressing their role in IBD management remains limited.

Objectives

This study aimed to systematically review the evidence on treatment adherence in IBD, with a focus on the potential role of clinical pharmacist counselling to improve medication adherence.

Methods

Three databases (PubMed, MEDLINE and Embase) were searched to identify relevant literature, using keywords derived from the PICO model.

Results

Seven full‐text articles met the inclusion criteria. Three of these reported that pharmacist involvement had a positive effect on treatment adherence in patients with IBD. Furthermore, two studies reported that pharmacist involvement in treatment improved disease activity. Patients' perceptions of pharmacist involvement were generally positive, particularly after receiving information about pharmacist services and education. Finally, studies also indicate that pharmacists require greater knowledge of IBD to provide optimal care.

Conclusion

Although the available literature is limited, it indicates that involving clinical pharmacists in IBD treatment may have a positive impact—improving medication adherence and enhancing disease control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesPharmacistsMedication AdherencePharmacy Service, HospitalHumansProfessional RoleQuality of LifePatient Education as Topic

Stichwörter der Autor:innen

clinical pharmacistdisease activityinflammatory bowel diseasepatient educationtreatment adherence

Autor:innen und Institutionen

  • University of Southern Denmark, Odense, Denmark.
  • Department of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.

ORCID-Profile: Faria Sayed, Mark Andrew Ainsworth

Zitieren

APA

Sayed, F., & Ainsworth, M. A. (2025). Adherence in the Treatment of Inflammatory Bowel Disease With Particular Focus on the Importance of the Clinical Pharmacist: A Systematic Review. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70125

Vancouver

Sayed F, Ainsworth MA. Adherence in the Treatment of Inflammatory Bowel Disease With Particular Focus on the Importance of the Clinical Pharmacist: A Systematic Review. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70125

BibTeX
@article{Sayed2025,
  author = {Sayed, Faria and Ainsworth, Mark Andrew},
  title = {Adherence in the Treatment of Inflammatory Bowel Disease With Particular Focus on the Importance of the Clinical Pharmacist: A Systematic Review},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  doi = {10.1111/bcpt.70125}
}
Kostenlos starten →